CN Stock MarketDetailed Quotes

603233 DaShenLin Pharmaceutical Group

Watchlist

14.41
-0.21-1.44%

Market Closed Jan 7 15:00 CST

16.41BMarket Cap19.29P/E (TTM)

DaShenLin Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DaShenLin Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 7.159B	--
--	2024/Q4	-- / 7.282B	--
Oct 31, 2024	2024/Q3	6.386B / 6.364B	--
Aug 31, 2024	2024/Q2	6.593B / 7.259B	--
--	2024/Q1	6.752B / 6.842B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 7.159B--

--2024/Q4-- / 7.282B--

Oct 31, 20242024/Q36.386B / 6.364B--

Aug 31, 20242024/Q26.593B / 7.259B--

--2024/Q16.752B / 6.842B--

Unlock Free Earnings Estimates

Open Account

DaShenLin Pharmaceutical Group Earnings Reports

Dashanlin: Dashanlin Pharmaceutical Group Co., Ltd. Third Quarter Report 2024

Oct 30, 2024 12:00 ET

Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the main operating data for the third quarter of 2024

Oct 30, 2024 12:00 ET

Dashenlin Pharmaceutical Group Co., Ltd. Report for the third quarter of 2024

Oct 30, 2024 12:00 ET

Dashenlin Pharmaceutical Group Co., Ltd. 2024 Semi-Annual Report

Aug 30, 2024 12:00 ET

Symbol Price % Chg

Hangzhou Huasu Technology

301157

58.54 +20.01%

Flaircomm Microelectronics, Inc.

See the daily top gainer.

Analysis

Analyst Rating

Updated: Jan 7, 2025

Strong Buy

Strong Buy
76.19%
Buy
23.81%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data